{
    "code": "10000780",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000780",
    "time": "2020-02-26 01:40:59",
    "許可證字號": "衛署菌疫輸字第000780號",
    "註銷狀態": "已註銷",
    "註銷日期": "94\/09\/16",
    "註銷理由": "自請註銷",
    "有效日期": "97\/11\/24",
    "發證日期": "92\/11\/24",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000078002",
    "中文品名": "貝靈血凝素第八因子注射劑 (重組體) 250IU\/VIAL",
    "英文品名": "HELIXATE FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FORMULATED WITH SUCROSE, 250IU\/VIAL",
    "適應症": "治療A型血友病。",
    "劑型": "243凍晶注射劑",
    "包裝": "250IU小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1426201100  臺灣拜耳股份有限公司",
        "申請商地址": "台北巿信義區信義路五段7號台北101大樓之53至54樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8004000140",
            "成分名稱": "ANTIHEMOPHILIC FACTOR RECOMBINANT FORMULATED WITH SUCROSE NOMINAL POTENCY",
            "含量描述": "",
            "含量": "250.0000000000",
            "單位": "I.U."
        }
    ]
}